These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 16574486

  • 1. Ions, energy and axonal injury: towards a molecular neurology of multiple sclerosis.
    Waxman SG.
    Trends Mol Med; 2006 May; 12(5):192-5. PubMed ID: 16574486
    [Abstract] [Full Text] [Related]

  • 2. Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models.
    Lassmann H.
    Exp Neurol; 2010 Sep; 225(1):2-8. PubMed ID: 19840788
    [Abstract] [Full Text] [Related]

  • 3. [Neuronal injury in multiple sclerosis].
    Correale J, Meli F, Ysrraelit C.
    Medicina (B Aires); 2006 Sep; 66(5):472-85. PubMed ID: 17137182
    [Abstract] [Full Text] [Related]

  • 4. The role of mitochondria in axonal degeneration and tissue repair in MS.
    van Horssen J, Witte ME, Ciccarelli O.
    Mult Scler; 2012 Aug; 18(8):1058-67. PubMed ID: 22723572
    [Abstract] [Full Text] [Related]

  • 5. Axonal conduction and injury in multiple sclerosis: the role of sodium channels.
    Waxman SG.
    Nat Rev Neurosci; 2006 Dec; 7(12):932-41. PubMed ID: 17115075
    [Abstract] [Full Text] [Related]

  • 6. Axonal loss in multiple sclerosis: causes and mechanisms.
    Criste G, Trapp B, Dutta R.
    Handb Clin Neurol; 2014 Dec; 122():101-13. PubMed ID: 24507515
    [Abstract] [Full Text] [Related]

  • 7. Mitochondrial dysfunction plays a key role in progressive axonal loss in Multiple Sclerosis.
    Andrews HE, Nichols PP, Bates D, Turnbull DM.
    Med Hypotheses; 2005 Dec; 64(4):669-77. PubMed ID: 15694681
    [Abstract] [Full Text] [Related]

  • 8. Pathogenesis of axonal and neuronal damage in multiple sclerosis.
    Dutta R, Trapp BD.
    Neurology; 2007 May 29; 68(22 Suppl 3):S22-31; discussion S43-54. PubMed ID: 17548565
    [Abstract] [Full Text] [Related]

  • 9. Neuroprotection and repair by neurotrophic and gliotrophic factors in multiple sclerosis.
    Loeb JA.
    Neurology; 2007 May 29; 68(22 Suppl 3):S38-42; discussion S43-54. PubMed ID: 17548567
    [Abstract] [Full Text] [Related]

  • 10. Sodium channels as molecular targets in multiple sclerosis.
    Waxman SG.
    J Rehabil Res Dev; 2002 May 29; 39(2):233-42. PubMed ID: 12051467
    [Abstract] [Full Text] [Related]

  • 11. Mechanisms of disease: sodium channels and neuroprotection in multiple sclerosis-current status.
    Waxman SG.
    Nat Clin Pract Neurol; 2008 Mar 29; 4(3):159-69. PubMed ID: 18227822
    [Abstract] [Full Text] [Related]

  • 12. Beta 2-adrenoceptor involvement in inflammatory demyelination and axonal degeneration in multiple sclerosis.
    De Keyser J, Zeinstra E, Mostert J, Wilczak N.
    Trends Pharmacol Sci; 2004 Feb 29; 25(2):67-71. PubMed ID: 15102491
    [Abstract] [Full Text] [Related]

  • 13. General mechanisms of axonal damage and its prevention.
    Stys PK.
    J Neurol Sci; 2005 Jun 15; 233(1-2):3-13. PubMed ID: 15899499
    [Abstract] [Full Text] [Related]

  • 14. Protecting axons in multiple sclerosis.
    Wilkins A, Scolding N.
    Mult Scler; 2008 Sep 15; 14(8):1013-25. PubMed ID: 18632772
    [Abstract] [Full Text] [Related]

  • 15. Changes at the nodal and perinodal axonal domains: a basis for multiple sclerosis pathology?
    Desmazières A, Sol-Foulon N, Lubetzki C.
    Mult Scler; 2012 Feb 15; 18(2):133-7. PubMed ID: 22217583
    [Abstract] [Full Text] [Related]

  • 16. Mechanisms of inflammation induced tissue injury in multiple sclerosis.
    Lassmann H.
    J Neurol Sci; 2008 Nov 15; 274(1-2):45-7. PubMed ID: 18495163
    [Abstract] [Full Text] [Related]

  • 17. Na+ channel expression along axons in multiple sclerosis and its models.
    Waxman SG, Craner MJ, Black JA.
    Trends Pharmacol Sci; 2004 Nov 15; 25(11):584-91. PubMed ID: 15491781
    [Abstract] [Full Text] [Related]

  • 18. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration.
    Hauser SL, Oksenberg JR.
    Neuron; 2006 Oct 05; 52(1):61-76. PubMed ID: 17015227
    [Abstract] [Full Text] [Related]

  • 19. Biological markers for axonal degeneration in CSF and blood of patients with the first event indicative for multiple sclerosis.
    Hein Née Maier K, Köhler A, Diem R, Sättler MB, Demmer I, Lange P, Bähr M, Otto M.
    Neurosci Lett; 2008 May 02; 436(1):72-6. PubMed ID: 18359164
    [Abstract] [Full Text] [Related]

  • 20. Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis.
    Zaveri MS, Conger A, Salter A, Frohman TC, Galetta SL, Markowitz CE, Jacobs DA, Cutter GR, Ying GS, Maguire MG, Calabresi PA, Balcer LJ, Frohman EM.
    Arch Neurol; 2008 Jul 02; 65(7):924-8. PubMed ID: 18625859
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.